(HOWL) Werewolf Therapeutics - Performance -54.3% in 12m
HOWL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-85.77%
#158 in Peer-Group
Rel. Strength
7.85%
#7095 in Stock-Universe
Total Return 12m
-54.27%
#140 in Peer-Group
Total Return 5y
-93.35%
#139 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.63 USD |
| 52 Week Low | 0.63 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 45.51 |
| Buy/Sell Signal +-5 | -0.30 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: HOWL (-54.3%) vs XBI (-6.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.92% | 72.5% | 80.4% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-8.48% | -6.85% | 159% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.26% | -3.11% | 38.6% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.07% | 32.1% | -2.24% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
6.19% | -6.83% | 5.89% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.6% | 39.2% | -5% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.71% | 54.5% | -7.69% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.98% | 29.3% | 17.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: HOWL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HOWL
| Total Return (including Dividends) | HOWL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -24.11% | 4.28% | 4.37% |
| 3 Months | 48.67% | 17.36% | 14.09% |
| 12 Months | -54.27% | -6.86% | 13.68% |
| 5 Years | -93.35% | -21.19% | 112.88% |
| Trend Score (consistency of price movement) | HOWL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -85.9% | 13.1% | 83.6% |
| 3 Months | 72.3% | 79.4% | 97.2% |
| 12 Months | -88.9% | -87.1% | 45.7% |
| 5 Years | -79.6% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th6.50 | -27.23% | -27.29% |
| 3 Month | %th73.00 | 26.68% | 30.31% |
| 12 Month | %th30.00 | -50.91% | -59.78% |
| 5 Years | %th36.00 | -89.69% | -95.81% |
FAQs
Does Werewolf Therapeutics (HOWL) outperform the market?
No,
over the last 12 months HOWL made -54.27%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.86%.
Over the last 3 months HOWL made 48.67%, while XBI made 17.36%.
Performance Comparison HOWL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
HOWL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -0.6% | -28.5% | -30.6% | -68% |
| US NASDAQ 100 | QQQ | -1% | -29% | -32.4% | -67% |
| German DAX 40 | DAX | -3.2% | -25.7% | -43.5% | -88% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.3% | -27.7% | -34.2% | -74% |
| Hongkong Hang Seng | HSI | 0.9% | -27.3% | -51.1% | -92% |
| India NIFTY 50 | INDA | -0.1% | -24.9% | -31.2% | -53% |
| Brasil Bovespa | EWZ | 2.6% | -28% | -48.9% | -59% |
HOWL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.4% | -27.9% | -34.8% | -78% |
| Consumer Discretionary | XLY | 0.5% | -26.7% | -22.1% | -71% |
| Consumer Staples | XLP | 1.7% | -23.9% | -29.6% | -62% |
| Energy | XLE | -1.3% | -30.3% | -23.7% | -57% |
| Financial | XLF | 0.4% | -27.2% | -34% | -82% |
| Health Care | XLV | -0.1% | -25.6% | -20.3% | -49% |
| Industrial | XLI | -1.2% | -28% | -37.3% | -80% |
| Materials | XLB | -0.4% | -28.5% | -33.7% | -62% |
| Real Estate | XLRE | 0.9% | -23.9% | -29.8% | -66% |
| Technology | XLK | -1.7% | -31.9% | -35.5% | -65% |
| Utilities | XLU | -0.8% | -26.3% | -32.4% | -77% |
| Aerospace & Defense | XAR | -1.7% | -28.8% | -49.2% | -104% |
| Biotech | XBI | -3.6% | -28.4% | -20.7% | -47% |
| Homebuilder | XHB | -1.2% | -33.4% | -25.5% | -62% |
| Retail | XRT | -0% | -26.2% | -24.4% | -65% |
HOWL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -1.8% | -30.9% | -17.9% | -51% |
| Natural Gas | UNG | 7.9% | -9.9% | 0.4% | -45% |
| Gold | GLD | 1.2% | -23.8% | -45.6% | -94% |
| Silver | SLV | 0.7% | -22.9% | -42% | -72% |
| Copper | CPER | -6.4% | -35.9% | -50% | -75% |
HOWL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.7% | -26.2% | -26.4% | -52% |
| iShares High Yield Corp. Bond | HYG | 0.1% | -25.7% | -27.6% | -64% |